Article Information
- Received January 6, 1997
- Accepted February 11, 1997
- First published May 1, 1997.
- Version of record published May 1, 1997.
Author Information
Author contributions
Disclosures
- Received January 6, 1997.
- Accepted February 11, 1997.
This work was supported by National Institutes of Health Grants AA07466, NS01898, NS32318, and NS31001; the Charles A. Dana Foundation (The Dana Clinical Hypotheses Research Program); the American Parkinson Disease Association; National Alliance for Research on Schizophrenia and Depression; and the McDonnell Center for Higher Brain Function. We gratefully acknowledge helpful discussions with Professor P. J. Bédard (Centre de Recherche en Neurobiologie, Hôpital de l’Enfant-Jésus, Québec, Canada), and Drs. M. F. Piercey and M. W. Moon (CNS Research, Pharmacı́a-Upjohn). U91356a was a generous gift of the Upjohn Company.
Correspondence should be addressed to Dr. Kevin John Black, Campus Box 8134, 4940 Children’s Place, St. Louis, MO 63110-1093.
Online Impact